Hosted on MSN
NRx eyes faster commercial path as NRX-101 moves into TMS-enhanced depression treatment
WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) expanded its development plan for NRX-101, amending its Investigational New Drug application to study the drug in combination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results